Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 2Psoriasis 1Plaque, Amyloid 1Dermatitis, Atopic 1

Interventions

itepekimab 2pimecrolimus 1dupilumab 1abrocitinib 1Urine Specimen Collection 1Tacrolimus 1Eating 1Broncho-Vaxom 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dermatitis, Atopic × abrocitinib × Clear all
NCT02780167 2019-05-02

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Pfizer

Phase 2 Completed
269 enrolled 31 charts
Lymphoid

Dermatitis, Atopic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡